Pharmaron Beijing Co., Limited: Pharmaron's Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment
Building capacity in Gene Therapy Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious
Source: finanznachrichten.de